Clinical Research Facility

Fort Mill, South Carolina 29707

We've found

2 trials

at this facility

One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease

Status: Enrolling, Phase III
Updated: 4/26/2017

from

Fort Mill, SC

Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Fort Mill, SC

Use our guide to learn which trials are right for you!